These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 34905555)

  • 1. Structural systems pharmacology: A framework for integrating metabolic network and structure-based virtual screening for drug discovery against bacteria.
    Nazarshodeh E; Marashi SA; Gharaghani S
    PLoS One; 2021; 16(12):e0261267. PubMed ID: 34905555
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibacterial mechanisms identified through structural systems pharmacology.
    Chang RL; Xie L; Bourne PE; Palsson BO
    BMC Syst Biol; 2013 Oct; 7():102. PubMed ID: 24112686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of natural compound inhibitors for multidrug efflux pumps of Escherichia coli and Pseudomonas aeruginosa using in silico high-throughput virtual screening and in vitro validation.
    Aparna V; Dineshkumar K; Mohanalakshmi N; Velmurugan D; Hopper W
    PLoS One; 2014; 9(7):e101840. PubMed ID: 25025665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteomics Evidence for the Activity of the Putative Antibacterial Plant Alkaloid (-)-Roemerine: Mainstreaming Omics-Guided Drug Discovery.
    Gokgoz NB; Akbulut BS
    OMICS; 2015 Aug; 19(8):478-89. PubMed ID: 26230533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapid countermeasure discovery against Francisella tularensis based on a metabolic network reconstruction.
    Chaudhury S; Abdulhameed MD; Singh N; Tawa GJ; D'haeseleer PM; Zemla AT; Navid A; Zhou CE; Franklin MC; Cheung J; Rudolph MJ; Love J; Graf JF; Rozak DA; Dankmeyer JL; Amemiya K; Daefler S; Wallqvist A
    PLoS One; 2013; 8(5):e63369. PubMed ID: 23704901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toward repurposing ciclopirox as an antibiotic against drug-resistant Acinetobacter baumannii, Escherichia coli, and Klebsiella pneumoniae.
    Carlson-Banning KM; Chou A; Liu Z; Hamill RJ; Song Y; Zechiedrich L
    PLoS One; 2013; 8(7):e69646. PubMed ID: 23936064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Downregulation of yidC in Escherichia coli by antisense RNA expression results in sensitization to antibacterial essential oils eugenol and carvacrol.
    Patil SD; Sharma R; Srivastava S; Navani NK; Pathania R
    PLoS One; 2013; 8(3):e57370. PubMed ID: 23469191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systems biology of the structural proteome.
    Brunk E; Mih N; Monk J; Zhang Z; O'Brien EJ; Bliven SE; Chen K; Chang RL; Bourne PE; Palsson BO
    BMC Syst Biol; 2016 Mar; 10():26. PubMed ID: 26969117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification and characterization of novel small molecule inhibitors of the acetyltransferase activity of Escherichia coli N-acetylglucosamine-1-phosphate-uridyltransferase/glucosamine-1-phosphate-acetyltransferase (GlmU).
    Sharma R; Rani C; Mehra R; Nargotra A; Chib R; Rajput VS; Kumar S; Singh S; Sharma PR; Khan IA
    Appl Microbiol Biotechnol; 2016 Apr; 100(7):3071-85. PubMed ID: 26563552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blueprint for antimicrobial hit discovery targeting metabolic networks.
    Shen Y; Liu J; Estiu G; Isin B; Ahn YY; Lee DS; Barabási AL; Kapatral V; Wiest O; Oltvai ZN
    Proc Natl Acad Sci U S A; 2010 Jan; 107(3):1082-7. PubMed ID: 20080587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acetate Kinase (AcK) is Essential for Microbial Growth and Betel-derived Compounds Potentially Target AcK, PhoP and MDR Proteins in M. tuberculosis, V. cholerae and Pathogenic E. coli: An in silico and in vitro Study.
    Tiwari S; Barh D; Imchen M; Rao E; Kumavath RK; Seenivasan SP; Jaiswal AK; Jamal SB; Kumar V; Ghosh P; Azevedo V
    Curr Top Med Chem; 2018; 18(31):2731-2740. PubMed ID: 30663567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolomics-Driven Exploration of the Chemical Drug Space to Predict Combination Antimicrobial Therapies.
    Campos AI; Zampieri M
    Mol Cell; 2019 Jun; 74(6):1291-1303.e6. PubMed ID: 31047795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of putative non-host essential genes and novel drug targets against Acinetobacter baumannii by in silico comparative genome analysis.
    Uddin R; Masood F; Azam SS; Wadood A
    Microb Pathog; 2019 Mar; 128():28-35. PubMed ID: 30550846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genome-scale metabolic models as platforms for identification of novel genes as antimicrobial drug targets.
    Mienda BS; Salihu R; Adamu A; Idris S
    Future Microbiol; 2018 Mar; 13():455-467. PubMed ID: 29469596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibitor discovery for the E. coli meningitis virulence factor IbeA from homology modeling and virtual screening.
    Xu X; Zhang L; Cai Y; Liu D; Shang Z; Ren Q; Li Q; Zhao W; Chen Y
    J Comput Aided Mol Des; 2020 Jan; 34(1):11-25. PubMed ID: 31792885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery of therapeutic agents for prostate cancer using genome-scale metabolic modeling and drug repositioning.
    Turanli B; Zhang C; Kim W; Benfeitas R; Uhlen M; Arga KY; Mardinoglu A
    EBioMedicine; 2019 Apr; 42():386-396. PubMed ID: 30905848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemical genomics in Escherichia coli identifies an inhibitor of bacterial lipoprotein targeting.
    Pathania R; Zlitni S; Barker C; Das R; Gerritsma DA; Lebert J; Awuah E; Melacini G; Capretta FA; Brown ED
    Nat Chem Biol; 2009 Nov; 5(11):849-56. PubMed ID: 19783991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative genomic analysis of Rickettsia rickettsii for identification of drug and vaccine targets: tolC as a proposed candidate for case study.
    Maurya PK; Singh S; Mani A
    Acta Trop; 2018 Jun; 182():100-110. PubMed ID: 29474831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Genome-Wide Interaction Network of Nutrient Stress Genes in Escherichia coli.
    Côté JP; French S; Gehrke SS; MacNair CR; Mangat CS; Bharat A; Brown ED
    mBio; 2016 Nov; 7(6):. PubMed ID: 27879333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phytochemicals increase the antibacterial activity of antibiotics by acting on a drug efflux pump.
    Ohene-Agyei T; Mowla R; Rahman T; Venter H
    Microbiologyopen; 2014 Dec; 3(6):885-96. PubMed ID: 25224951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.